Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial

Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial

Background One‐quarter of all strokes are subsequent events. It is not known whether higher levels of blood glucose are associated with an increased risk of subsequent stroke after high‐risk transient ischemic attack or minor ischemic stroke. Methods and Results We performed a secondary analysis of...

Full description

Bibliographic Details
Main Authors: Brian Mac Grory, Jonathan P. Piccini, Shadi Yaghi, Sven Poli, Adam De Havenon, Sara K. Rostanski, Martin Weiss, Ying Xian, S. Claiborne Johnston, Wuwei Feng
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
antithrombotic therapy
clinical trial
diabetes
hyperglycemia
ischemic stroke
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023223

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.023223

Similar Items